Table 2.
Cancer Incidence Rates by Timing of Diagnosis After Antiretroviral Therapy Initiation
| Timing of Diagnosis | Men | Women | ||
|---|---|---|---|---|
| Incidence Rate | (95% CI) | Incidence Rate | (95% CI) | |
| All sites, total | 765.5 | (621.7–909.3) | 643.3 | (543.6–743.0) |
| Early incidence | 534.7 | (417.5–651.9) | 399.1 | (324.5–473.7) |
| Late incidence | 230.8 | (147.5–314.2) | 244.2 | (178.0–310.4) |
| Kaposi sarcoma | ||||
| Early incidence | 525.0 | (407.9–642.1) | 371.7 | (298.2–445.2) |
| Late incidence | 203.4 | (126.3–280.5) | 202.8 | (140.0–265.6) |
| Cervical cancer | ||||
| Early incidence | … | … | 13.7 | (7.7–19.7) |
| Late incidence | … | … | 22.9 | (9.0–36.8) |
Incidence rates are per 100 000 person-years on antiretroviral therapy (ART) and are age-adjusted to the 2007 Malawi standard population. Cancer sites include invasive cases only. Early incidence is defined as 4 to 24 months after start of ART; late incidence is defined as >24 months after start of ART.
Abbreviation: CI, confidence interval.